147 related articles for article (PubMed ID: 17456873)
41. Re-188 lipiodol in hepatocellular carcinoma with portal vein thrombosis: a pilot study using novel chelating agent N-DEDC and its comparison with (A)HDD.
Datta Gupta SS; Shamim SA; Gamanagatti S; Gupta P; Khan MA; Mallia MB; Chirayil V; Dash A; Bal C
Nucl Med Commun; 2024 Jun; 45(6):510-518. PubMed ID: 38632971
[TBL] [Abstract][Full Text] [Related]
42. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
[TBL] [Abstract][Full Text] [Related]
43. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.
N'Kontchou G; Mahamoudi A; Aout M; Ganne-Carrié N; Grando V; Coderc E; Vicaut E; Trinchet JC; Sellier N; Beaugrand M; Seror O
Hepatology; 2009 Nov; 50(5):1475-83. PubMed ID: 19731239
[TBL] [Abstract][Full Text] [Related]
44. Large (>or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes--initial experience in 26 patients.
Seror O; N'Kontchou G; Ibraheem M; Ajavon Y; Barrucand C; Ganne N; Coderc E; Trinchet JC; Beaugrand M; Sellier N
Radiology; 2008 Jul; 248(1):288-96. PubMed ID: 18483229
[TBL] [Abstract][Full Text] [Related]
45. Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapy.
Jeong JM; Knapp FF
Semin Nucl Med; 2008 Mar; 38(2):S19-29. PubMed ID: 18243839
[TBL] [Abstract][Full Text] [Related]
46. Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.
Bretagne JF; Raoul JL; Bourguet P; Duvauferrier R; Deugnier Y; Faroux R; Ramée A; Herry JY; Gastard J
Radiology; 1988 Aug; 168(2):547-50. PubMed ID: 2839867
[TBL] [Abstract][Full Text] [Related]
47. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
48. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
[TBL] [Abstract][Full Text] [Related]
49. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
[TBL] [Abstract][Full Text] [Related]
50. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images.
Takaki H; Yamakado K; Nakatsuka A; Yamada T; Uraki J; Kashima M; Yamanaka T; Shiraki K; Takei Y; Takeda K
Int J Clin Oncol; 2013 Feb; 18(1):46-53. PubMed ID: 22016114
[TBL] [Abstract][Full Text] [Related]
51. Treatment of unresectable hepatocellular carcinoma with radiolabelled lipiodol.
Kanhere HA; Leopardi LN; Fischer L; Kitchener MI; Maddern GJ
ANZ J Surg; 2008 May; 78(5):371-6. PubMed ID: 18380736
[TBL] [Abstract][Full Text] [Related]
52. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
O'Suilleabhain CB; Poon RT; Yong JL; Ooi GC; Tso WK; Fan ST
Br J Surg; 2003 Mar; 90(3):325-31. PubMed ID: 12594668
[TBL] [Abstract][Full Text] [Related]
53. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol.
Raoul JI; Bretagne JF; Caucanas JP; Pariente EA; Boyer J; Paris JC; Michel H; Bourguet P; Victor G; Therain F
Cancer; 1992 Jan; 69(2):346-52. PubMed ID: 1309429
[TBL] [Abstract][Full Text] [Related]
54. [How I treat... An hepatocellular carcinoma: role of selective internal radiation therapy with intra-arterial iodine-131].
Werenne X
Rev Med Liege; 2007 Oct; 62(10):603-6. PubMed ID: 18069570
[TBL] [Abstract][Full Text] [Related]
55. 188rhenium-TDD-lipiodol in treatment of inoperable primary hepatocellular carcinoma--a case report.
Sundram FX; Yu SW; Jeong JM; Somanesan S; Premaraj J; Saw MM; Tan BS
Ann Acad Med Singap; 2001 Sep; 30(5):542-5. PubMed ID: 11603144
[TBL] [Abstract][Full Text] [Related]
56. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
[TBL] [Abstract][Full Text] [Related]
57. Two Cases of 188Re Microspheres for Inoperable Hepatocellular Carcinoma.
Shukla J; Kalra N; Kumar R; Bhusari P; Chhabra A; Parmar M; Vatsa R; Singh H; Duseja A; Mittal BR
Clin Nucl Med; 2019 Feb; 44(2):e93-e95. PubMed ID: 30418210
[TBL] [Abstract][Full Text] [Related]
58. Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II clinical study.
Takaki H; Yamakado K; Tsurusaki M; Yasumoto T; Baba Y; Narimatsu Y; Shimohira M; Yamaguchi M; Matsuo K; Inaba Y; Mikami K; Watanabe R; Nishida N; Anai H; Kakizawa H; Hirota S
Int J Clin Oncol; 2015 Aug; 20(4):745-54. PubMed ID: 25432660
[TBL] [Abstract][Full Text] [Related]
59. Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution.
Yumoto Y; Jinno K; Inatsuki S; Moriwaki S; Hanafusa T; Yumoto E; Shiota T; Higashi T; Koide N; Hada H
Cancer Chemother Pharmacol; 1992; 31 Suppl():S128-36. PubMed ID: 1281043
[TBL] [Abstract][Full Text] [Related]
60. Survival after 131I-labeled lipiodol therapy for hepatocellular carcinoma. A single-center study based on a long-term follow-up.
Ahmadzadehfar H; Habibi E; Ezziddin S; Wilhelm K; Fimmers R; Spengler U; Palmedo H; Strunk H; Schild HH; Biersack HJ; Risse J
Nuklearmedizin; 2014; 53(2):46-53. PubMed ID: 24468919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
